Lupin launches Rufinamide Tablets USP in the US EP News Bureau Dec 6, 2022 Rufinamide is indicated for the treatment of the symptoms of Lennox-Gastaut Syndrome
Lupin receives US FDA approval for Rufinamide tablets EP News Bureau Aug 18, 2022 The product will be manufactured at Lupin’s facility in Goa
Glenmark launches Rufinamide Tablets USP, 200 mg and 400 mg EP News Bureau Jun 1, 2021 It is indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) along with other medicines
